Table 1
Open in new tab

Baseline characteristics of the patient cohort

Number of patients51
Demographic data
 Age (years)61 ± 10
 Male gender29 (57%)
 BMI (kg/m2)25.8 ± 4.0
Medical history and risk factors
 Known CAD history23 (45%)
  Prior PCI16 (31%)
  Prior MI13 (26%)
 Hypertension22 (43%)
 Dyslipidaemia15 (29%)
 Diabetes mellitus8 (16%)
 Smoking18/50 (36%)
 Family history of CAD14/49 (29%)
Medication
 Aspirin29/50 (58%)
 Beta-blockers21/50 (42%)
 ACEI or ARB18/50 (36%)
 Calcium channel blockers17/50 (34%)
 Statin28/50 (56%)
Number of patients51
Demographic data
 Age (years)61 ± 10
 Male gender29 (57%)
 BMI (kg/m2)25.8 ± 4.0
Medical history and risk factors
 Known CAD history23 (45%)
  Prior PCI16 (31%)
  Prior MI13 (26%)
 Hypertension22 (43%)
 Dyslipidaemia15 (29%)
 Diabetes mellitus8 (16%)
 Smoking18/50 (36%)
 Family history of CAD14/49 (29%)
Medication
 Aspirin29/50 (58%)
 Beta-blockers21/50 (42%)
 ACEI or ARB18/50 (36%)
 Calcium channel blockers17/50 (34%)
 Statin28/50 (56%)

Categorical variables are presented as number and percentage. Continuous variables are expressed as mean ± SD.

ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers; BMI, body mass index; CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Table 1
Open in new tab

Baseline characteristics of the patient cohort

Number of patients51
Demographic data
 Age (years)61 ± 10
 Male gender29 (57%)
 BMI (kg/m2)25.8 ± 4.0
Medical history and risk factors
 Known CAD history23 (45%)
  Prior PCI16 (31%)
  Prior MI13 (26%)
 Hypertension22 (43%)
 Dyslipidaemia15 (29%)
 Diabetes mellitus8 (16%)
 Smoking18/50 (36%)
 Family history of CAD14/49 (29%)
Medication
 Aspirin29/50 (58%)
 Beta-blockers21/50 (42%)
 ACEI or ARB18/50 (36%)
 Calcium channel blockers17/50 (34%)
 Statin28/50 (56%)
Number of patients51
Demographic data
 Age (years)61 ± 10
 Male gender29 (57%)
 BMI (kg/m2)25.8 ± 4.0
Medical history and risk factors
 Known CAD history23 (45%)
  Prior PCI16 (31%)
  Prior MI13 (26%)
 Hypertension22 (43%)
 Dyslipidaemia15 (29%)
 Diabetes mellitus8 (16%)
 Smoking18/50 (36%)
 Family history of CAD14/49 (29%)
Medication
 Aspirin29/50 (58%)
 Beta-blockers21/50 (42%)
 ACEI or ARB18/50 (36%)
 Calcium channel blockers17/50 (34%)
 Statin28/50 (56%)

Categorical variables are presented as number and percentage. Continuous variables are expressed as mean ± SD.

ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers; BMI, body mass index; CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close